This site is intended for health professionals only

array(11) { ["handbook__kind_of_sponsors"]=> string(3) "pdf" ["handbook__sponsored_page"]=> bool(false) ["handbook__title_to_show"]=> string(72) " Evidence and guidance in treating adults with long-term insomnia: TA922" ["handbook__job_code"]=> string(23) "July 2024 | UK-DA-00510" ["handbook__sponsored_logo"]=> string(139) "https://www.pulsetoday.co.uk/wp-content/uploads/2024/08/AP2405-PULSETODAY-UPLOAD-NICE-IDORSIA-ABRIDGED-A5-HANDBOOK-DEV00006080-HappyFox.jpg" ["handbook__sponsored_front_cover"]=> bool(false) ["handbook__sponsored_pdf"]=> bool(false) ["handbook__article_category"]=> array(1) { [0]=> int(120) } ["handbook__sponsored_tracking_pdf"]=> string(132) "https://www.pulsetoday.co.uk/wp-content/uploads/trackedfiles/1724253702-ap2405-nice-idorsia-handbook-a5-v10-digital-single-pages.pdf" ["sponsored_logo_portrait"]=> bool(true) ["handbook__disclaimer"]=> string(168) "

This summary of NICE technology appraisal guidance TA922 is funded by Idorsia Pharmaceuticals Ltd and is intended for UK healthcare professionals only.

" }

Mental health, pain and addiction